ConductScience.org, home

Paper41739293

Curcumin-mediated modulation of immunogenic cancer cell death pathways.

Moon DO. Mol Biol Rep, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Curcumin-mediated modulation of immunogenic cancer cell death pathways. Papers, record 41739293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41739293

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Curcumin-mediated modulation of immunogenic cancer cell death pathways.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moon DODong Oh

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CurcuminMajor topic
Immunogenic Cell DeathMajor topic
NeoplasmsMajor topic
Humans
Signal Transduction
Animals
Calreticulin
HMGB1 Protein
Endoplasmic Reticulum Stress
Oxidative Stress
Alarmins
Dendritic Cells
Ferroptosis

Source PubMed

Download CSV of topics

References71

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117187072Calreticulin exposure dictates the immunogenicity of cancer cell death.Nat Med2007https://conductscience.org/library/papers/17187072PubMed
232899721Hsp70 and NF-kB Mediated Control of Innate Inflammatory Responses in a Canine Macrophage Cell Line.Int J Mol Sci2020https://conductscience.org/library/papers/32899721PubMed
334298639Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34298639PubMed
431736963DAMPs and NETs in Sepsis.Front Immunol2019https://conductscience.org/library/papers/31736963PubMed
539061221The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management.Cancers (Basel)2024https://conductscience.org/library/papers/39061221PubMed
620192808HMGB1 and RAGE in inflammation and cancer.Annu Rev Immunol2010https://conductscience.org/library/papers/20192808PubMed
734095313Curcumin Targets Both Apoptosis and Necroptosis in Acidity-Tolerant Prostate Carcinoma Cells.Biomed Res Int2021https://conductscience.org/library/papers/34095313PubMed
827837604Curcumin (Turmeric) and cancer.J BUON2016https://conductscience.org/library/papers/27837604PubMed
939963419Acid-Unlocked Two-Layer Ca-Loaded Nanoplatform to Interfere With Mitochondria for Synergistic Tumor Therapy.Int J Nanomedicine2025https://conductscience.org/library/papers/39963419PubMed
1040999987Curcumin exerts therapeutic effects on colorectal cancer by inducing pyroptosis through caspase‑1 activation.Mol Med Rep2025https://conductscience.org/library/papers/40999987PubMed
1116142732RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.Arthritis Rheum2005https://conductscience.org/library/papers/16142732PubMed
1238126694Tumor Microenvironment-Specific Driven Nanoagents for Synergistic Mitochondria Damage-Related Immunogenic Cell Death and Alleviated Immunosuppression.Small Methods2024https://conductscience.org/library/papers/38126694PubMed
1329751146Curcumin enhances anti-tumor immune response in tongue squamous cell carcinoma.Arch Oral Biol2018https://conductscience.org/library/papers/29751146PubMed
1423800749ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.Autophagy2013https://conductscience.org/library/papers/23800749PubMed
1531590362Curcumin and Cancer.Nutrients2019https://conductscience.org/library/papers/31590362PubMed
1634006390The Nexus of cfDNA and Nuclease Biology.Trends Genet2021https://conductscience.org/library/papers/34006390PubMed
1711687887Rac1 regulates heat shock responses by reorganization of vimentin filaments: identification using MALDI-TOF MS.Cell Death Differ2001https://conductscience.org/library/papers/11687887PubMed
1827199984Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity.Front Immunol2016https://conductscience.org/library/papers/27199984PubMed
1939349408NIR Enhanced pH-Responsive Microneedles for Synergetic Therapy of Melanoma.ChemMedChem2025https://conductscience.org/library/papers/39349408PubMed
2026942057Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancer.Oncoimmunology2016https://conductscience.org/library/papers/26942057PubMed

See all 71 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CALR811PubTator's text mininghttps://conductscience.org/library/genes/811NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41739293

GET https://conductscience.org/api/papers/v1/41739293/references?page=2